We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YCBD icon
7301
cbdMD
YCBD
$5.98M
$7K ﹤0.01%
5
+3
+150% +$4.93K
QXO
7302
QXO Inc
QXO
$14.7B
$7K ﹤0.01%
+215
New +$6.85K
HURA
7303
TuHURA Biosciences
HURA
$139M
$7K ﹤0.01%
1
FSGS
7304
First Trust SMID Growth Strength ETF
FSGS
$31.2M
$7K ﹤0.01%
+302
New +$6.66K
AUMN
7305
DELISTED
Golden Minerals Company
AUMN
$7K ﹤0.01%
761
+608
+397% +$6.03K
DALT
7306
DELISTED
Anfield Diversified Alternatives ETF
DALT
$7K ﹤0.01%
+705
New +$7.08K
PATI
7307
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$7K ﹤0.01%
328
+150
+84% +$2.99K
LTRPB
7308
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
$7K ﹤0.01%
434
+430
+10,750% +$5.91K
EVLO
7309
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$7K ﹤0.01%
+31
New +$9.04K
BCM
7310
DELISTED
iPath Pure Beta Broad Commodity ETN
BCM
$7K ﹤0.01%
241
-313
-56% -$9.53K
VYNT
7311
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$7K ﹤0.01%
57
-349
-86% -$52.8K
NVCN
7312
DELISTED
Neovasc Inc.
NVCN
$7K ﹤0.01%
7
+3
+75% +$3.1K
MENV
7313
DELISTED
AdvisorShares North Square McKee ESG Core Bond ETF
MENV
$7K ﹤0.01%
+257
New +$6.55K
IFMK
7314
DELISTED
iFresh Inc. Common Stock
IFMK
$7K ﹤0.01%
1,282
+558
+77% +$3.62K
SPRT
7315
DELISTED
support.com, Inc.
SPRT
$7K ﹤0.01%
2,590
-2,969
-53% -$8.38K
ALSK
7316
DELISTED
Alaska Communications Systems
ALSK
$7K ﹤0.01%
3,728
-16,002
-81% -$26.3K
MDLY
7317
DELISTED
Medley Management Inc
MDLY
$7K ﹤0.01%
188
+57
+44% +$2.72K
GEN
7318
DELISTED
Genesis Healthcare, Inc.
GEN
$7K ﹤0.01%
3,126
-26,272
-89% -$50.8K
OVLU
7319
DELISTED
Invesco Russell 1000 Value Factor ETF
OVLU
$7K ﹤0.01%
+250
New +$6.45K
AWSM
7320
DELISTED
Cool Holdings Inc. Common Stock
AWSM
$7K ﹤0.01%
1,894
+1,319
+229% +$5.32K
NVLN
7321
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$7K ﹤0.01%
1,957
+1,930
+7,148% +$7.75K
HLTH
7322
DELISTED
Nobilis Health Corp.
HLTH
$7K ﹤0.01%
5,984
+968
+19% +$1.34K
ADOM
7323
DELISTED
ADOMANI Inc
ADOM
$7K ﹤0.01%
6,458
+1,292
+25% +$1.31K
WMGIZ
7324
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$7K ﹤0.01%
5,457
+200
+4% +$261
LCAHW
7325
DELISTED
Landcadia Holdings, Inc. Warrant
LCAHW
$7K ﹤0.01%
+8,397
New +$5.87K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.